Enveric Biosciences P/E Ratio

Enveric Biosciences (ENVB) currently reports a P/E ratio of -0.1. That is below the Technology sector average of 25.78. Use the charts on this page to explore Enveric Biosciences's P/E ratio history and peer comparisons.

Enveric Biosciences's P/E ratio of -0.1 is lower than the Technology sector average of 25.78. That is roughly 100.4% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Enveric Biosciences's market price to a fundamental measure such as earnings, sales, or book value. At -0.1, ENVB can look expensive or cheap only in context — versus its own history, growth rate, and Technology peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -0.1, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 25.78. From there, open related valuation or income-statement pages for Enveric Biosciences, and consider following ENVB for alerts when major investors trade the stock.

Enveric Biosciences is classified in the Technology sector. On P/E ratio, it currently shows -0.1 versus a sector average near 25.78. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing ENVB with unrelated industries.